Human Immunodeficiency Virus Type-2 Vpx (HIV-2 Vpx) (AA 1-113) Antikörper (FITC)
Kurzübersicht für Human Immunodeficiency Virus Type-2 Vpx (HIV-2 Vpx) (AA 1-113) Antikörper (FITC) (ABIN7156079)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-113
-
Virus Strain
- isolate BEN
-
Verwendungszweck
- vpx Antibody, FITC conjugated
-
Kreuzreaktivität
- Human Immunodeficiency Virus (HIV)
-
Aufreinigung
- Protein G purified
-
Reinheit
- >95 %
-
Immunogen
- Recombinant Human immunodeficiency virus type 2 subtype A Protein Vpx protein (1-113AA)
-
Isotyp
- IgG
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Human Immunodeficiency Virus Type-2 Vpx (HIV-2 Vpx)
-
Andere Bezeichnung
- HIV (isolate BEN) (HIV-2) vpx
-
Substanzklasse
- Viral Protein
-
Hintergrund
-
Background: Plays a role in nuclear translocation of the viral pre-integration complex (PIC), thus is required for the virus to infect non-dividing cells. Targets specific host proteins for degradation by the 26S proteasome. Acts by associating with the cellular CUL4A-DDB1 E3 ligase complex through direct interaction with host VPRPB/DCAF-1. This change in the E3 ligase substrate specificity results in the degradation of host SAMHD1. In turn, SAMHD1 depletion allows viral replication in host myeloid cells by preventing SAMHD1-mediated hydrolysis of intracellular dNTPs necessary for reverse transcription.
Aliases: vpxProtein Vpx antibody, Viral protein X antibody, X ORF protein antibody
-
UniProt
- P18099
Target
-